Medtronic completes €1.5 billion public offering of senior notes

Medtronic plc, a global healthcare technology company based in Galway, Ireland, has recently concluded a public offering of senior notes that amounted to €1.5 billion. These senior notes included €750,000,000 principal amount of 2.950% senior notes due 2030 and €750,000,000 principal amount of 4.200% senior notes due 2045. All Medtronic’s obligations under these notes are backed by full and unconditional guarantees from the company and Medtronic Global Holdings S.C.A., its wholly-owned subsidiary, which acts as the parent company of Medtronic, Inc. The net proceeds from this offering total approximately €1.49 billion after deducting underwriting discounts and related expenses. The company plans to use these funds to repay existing 0.000% Senior Notes and 2.625% Senior Notes due in 2025, which are associated with Medtronic Luxco.

Deutsche Bank AG, London Branch, and Goldman Sachs & Co. LLC served as the primary joint book-running managers for this public offering. Anyone interested in obtaining further details about the offering can access free copies of the Prospectus, which includes all relevant information, by visiting the U.S. Securities and Exchange Commission website or contacting the bank representatives for more information.

Medtronic aspires to address the most challenging health problems by finding innovative solutions. With a mission to alleviate pain, restore health, and prolong life, the company’s dedicated global team of over 95,000 individuals across 150 countries consistently delivers transformative technologies that treat 70 health conditions. Their products range from cardiac devices and surgical robotics to insulin pumps and patient monitoring systems, all aimed at enhancing patient care and outcomes worldwide.

In considering Medtronic’s forward-looking statements, it is essential to take note of the risk factors outlined in the prospectus and filings with the SEC, as well as the cautionary statements made by the company. Medtronic has always been committed to providing cutting-edge technologies and solutions that significantly impact the lives of countless individuals worldwide.

These recent financial announcements by Medtronic signify the company’s ongoing commitment to innovative healthcare solutions and its dedication to improving patient outcomes globally. With its bold thinking and even bolder actions, Medtronic continues to set a standard for the industry and demonstrates its relentless pursuit of excellence in healthcare technology.